BioTelemetry, Inc. to Release Second Quarter 2017 Earnings Results on August 8, 2017
Jul 31, 2017 12:05 pm UTC| Business
MALVERN, Pa., July 31, 2017 -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2017 earnings on Tuesday, August 8 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at...
Jul 31, 2017 12:05 pm UTC| Business
SAN DIEGO, July 31, 2017 -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced it has received a three-year, $1.7 million grant from the National Institutes of Health (“NIH”) to collaboratively study...
ASML reports transactions under its current share buyback program
Jul 31, 2017 12:01 pm UTC| Business
VELDHOVEN, the Netherlands - ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average price Total repurchased...
Jul 31, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., July 31, 2017 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
Penn Virginia Announces Accretive Acquisition in Core Area
Jul 31, 2017 12:01 pm UTC| Business
---Increases Core Leasehold Position and Production By Approximately 30%------Capitalizes on Strong Recent Well Results and Adds Drilling Inventory--- HOUSTON, July 31, 2017 -- Penn Virginia Corporation ("Penn...
Intellipharmaceutics Intends to Vigorously Defend Recently Filed Purported Class Action Lawsuit
Jul 31, 2017 12:01 pm UTC| Business
TORONTO, July 31, 2017 -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of...
Jul 31, 2017 12:01 pm UTC| Business
The independent Data and Safety Monitoring Board (DSMB) reviewed safety and efficacy data, of which RedHill remains blinded, from the first 222 subjects who have completed week 26 assessments in the Phase III MAP US...